Coronado Biosciences, Inc. (CNDO) was a big mover last session, as the company saw its shares rise by nearly 27% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up more than 85% in the past one-month time frame.
The company has seen four positive estimate revisions in the past 60 days and the Zacks Consensus Estimate moved higher over the same period of time, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Coronado currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Some better-ranked medical stocks worth considering include Lannett Company, Inc. (LCI), Jazz Pharmaceuticals plc (JAZZ) and Questcor Pharmaceuticals, Inc. (QCOR). All these companies sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment